A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL – Beigene

⟵ Back to Search Results

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

Beigene Study ID

BGB-3111-304

ClinicalTrials.gov ID

NCT03336333

EudraCT Number

2017-001551-31

China Drug Trials ID

CTR20190416

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents